Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Feb 14, 2009; 15(6): 732-736
Published online Feb 14, 2009. doi: 10.3748/wjg.15.732
Published online Feb 14, 2009. doi: 10.3748/wjg.15.732
Groups | Preoperation | 1 d post-operation | 1 wk post-operation | 2 wk post-operation | 3 wk post-operation | 4 wk post-operation |
AST (U/L) | ||||||
SO | 38.3 ± 2.4 | 38.1 ± 2.6 | 38.0 ± 2.4 | 38.7 ± 2.3 | 38.5 ± 2.1 | 39.1 ± 3.3 |
ABO-1 h | 38.2 ± 2.3 | 260.3 ± 19.51 | 85.0 ± 11.11 | 39.0 ± 1.6 | 38.2 ± 2.5 | 39.0 ± 3.3 |
ABO-2 h | 40.1 ± 1.7 | 359.9 ± 11.92 | 154.8 ± 14.42 | 86.9 ± 5.72 | 39.1 ± 1.7 | 38.8 ± 1.9 |
ABO-3 h | 39.8 ± 4.6 | 461.9 ± 11.43 | 199.2 ± 16.93 | 112.0 ± 16.73 | 82.7 ± 9.73 | 40.1 ± 3.6 |
ALT (U/L) | ||||||
SO | 42.2 ± 2.2 | 42.0 ± 2.3 | 43.2 ± 2.0 | 40.0 ± 3.7 | 40.7 ± 3.4 | 42.0 ± 2.3 |
ABO-1 h | 42.0 ± 2.4 | 200.5 ± 13.01 | 169.8 ± 14.31 | 65.9 ± 11.51 | 42.3 ± 2.8 | 43.2 ± 2.0 |
ABO-2 h | 43.9 ± 2.3 | 400.1 ± 12.32 | 200.2 ± 12.02 | 92.2 ± 8.62 | 42.7 ± 3.1 | 42.2 ± 3.7 |
ABO-3 h | 43.8 ± 4.6 | 505.9 ± 14.03 | 292.0 ± 15.83 | 116.6 ± 9.03 | 87.7 ± 8.83 | 44.6 ± 2.5 |
ALP (U/L) | ||||||
SO | 117.0 ± 14.7 | 115.9 ± 15.9 | 114.3 ± 14.8 | 110.3 ± 9.6 | 113.3 ± 12.7 | 111.4 ± 11.7 |
ABO-1 h | 117.6 ± 14.5 | 203.9 ± 18.81 | 139.8 ± 10.31 | 119.6 ± 9.01 | 112.5 ± 9.3 | 109.5 ± 7.5 |
ABO-2 h | 118.8 ± 14.2 | 304.8 ± 16.82 | 173.1 ± 11.22 | 136.2 ± 6.62 | 138.8 ± 6.32 | 139.6 ± 7.42 |
ABO-3 h | 113.9 ± 11.7 | 440.0 ± 29.43 | 226.0 ± 13.73 | 183.7 ± 9.83 | 149.4 ± 10.23 | 149.7 ± 11.53 |
GGT (U/L) | ||||||
SO | 16.7 ± 2.1 | 17.5 ± 2.5 | 18.0 ± 2.1 | 18.5 ± 2.6 | 18.8 ± 3.9 | 17.3 ± 2.3 |
ABO-1 h | 18.7 ± 2.2 | 62.8 ± 10.21 | 20.3 ± 3.4 | 17.3 ± 2.8 | 19.7 ± 3.5 | 17.5 ± 2.5 |
ABO-2 h | 17.7 ± 2.8 | 111.5 ± 9.22 | 106.5 ± 11.32 | 81.9 ± 7.62 | 84.7 ± 9.42 | 59.6 ± 13.62 |
ABO-3 h | 17.9 ± 3.0 | 214.6 ± 18.63 | 182.5 ± 8.63 | 153.7 ± 14.43 | 155.9 ± 19.33 | 98.0 ± 6.83 |
TBIL (&mgr;mol/L) | ||||||
SO | 10.0 ± 2.0 | 9.5 ± 1.7 | 10.4 ± 2.0 | 10.1 ± 1.9 | 10.6 ± 2.2 | 10.8 ± 2.3 |
ABO-1 h | 10.1 ± 1.8 | 21.0 ± 3.11 | 10.6 ± 2.4 | 9.8 ± 1.6 | 9.5 ± 2.0 | 10.5 ± 2.3 |
ABO-2 h | 9.9 ± 2.2 | 30.7 ± 2.32 | 19.8 ± 1.92 | 10.5 ± 2.2 | 9.3 ± 1.5 | 9.9 ± 2.0 |
ABO-3 h | 9 .7 ± 1.9 | 40.7 ± 4.33 | 30.6 ± 2.43 | 18.1 ± 2.23 | 10.3 ± 1.8 | 11.2 ± 2.3 |
DBIL (&mgr;mol/L) | ||||||
SO | 3.9 ± 1.0 | 3.8 ± 1.5 | 3.9 ± 1.3 | 4.9 ± 1.6 | 4.5 ± 1.1 | 5.5 ± 1.2 |
ABO-1 h | 4.7 ± 1.3 | 13.5 ± 2.51 | 4.2 ± 1.3 | 4.8 ± 0.8 | 4.1 ± 1.2 | 4.6 ± 0.8 |
ABO-2 h | 4.3 ± 1.3 | 20.4 ± 2.82 | 13.4 ± 2.22 | 4.9 ± 1.1 | 3.9 ± 1.1 | 4.6 ± 1.3 |
ABO-3 h | 4.5 ± 1.1 | 33.7 ± 3.03 | 19.6 ± 1.73 | 11.2 ± 2.03 | 5.0 ± 1.4 | 4.8 ± 1.5 |
- Citation: Sheng QS, Chen DZ, Lang R, He Q, Yang YJ, Qu ZW, Zhao DF, Zhang XS. Establishment of an animal model of ischemic type intrahepatic biliary lesion in rabbits. World J Gastroenterol 2009; 15(6): 732-736
- URL: https://www.wjgnet.com/1007-9327/full/v15/i6/732.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.732